SARCOIDOSIS RESEARCH INSTITUTE (EIN 621472852) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

PAMELA ROBERSON

Phone

9012338249

Tax Period

2024-01-01 to 2024-12-31

SARCOIDOSIS RESEARCH INSTITUTE, founded in 2018, is a micro nonprofit in the Medical Research sector that reported $5K in total revenue in fiscal year 2024. Revenue surged 113% from the prior year, signaling strong growth momentum. Expenses of $11K exceeded revenue, resulting in a 117% operating deficit.

Mission

TO CREATE AND DELIVER LEADING EDGE AND INNOVATIVE EDUCATIONAL EXPERIENCE WHICH ADDRESS THE MANY ASPECTS OF SARCOIDOSIS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $5,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $5,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $5,000

Other Expenses $10,848

TOTAL EXPENSES $10,848

Year-over-Year Comparison

	2024	2023	Change
Revenue	$5,000	$2,350	+1.1%
Expenses	$10,848	$76,350	-0.9%
Net Income	$-5,848	$-74,000	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

N/A

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$72,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PAULA POLITE	EXECUTIVE DIRECTOR	35.00	Director	$72,000	$0	$72,000
SANDRA REED	VICE PRESIDENT	0.00	Officer	$0	$0	$0
BARBARA BUFORD	MEMBER	0.00	Officer	$0	$0	$0
ADIRA POLITE	SECRETARY	0.00	Officer	$0	$0	$0
ARCHIE WILLIS III	TREASURER	0.00	Officer	$0	$0	$0
PAMELA ROBERSON	PRESIDENT	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$5,000	$10,848	$204,366	$-5,848
2023	$2,350	$76,350	$276,742	$-74,000
2022	No data	$74,885	No data	No data
2021	$1,071	$16,518	$430,944	$-15,447
2020	$1,405	$16,518	$439,957	$-15,113
2019	$432,617	$48,123	$1	$384,494

SARCOIDOSIS RESEARCH INSTITUTE